<DOC>
	<DOCNO>NCT02234830</DOCNO>
	<brief_summary>Is ExoSeal VSD non-inferior Angio-Seal vascular closure device ( VSD ) incidence adverse access site related event 30 day .</brief_summary>
	<brief_title>Randomized Comparison ExoSeal® Angio-Seal Vascular Closure Devices : The CLOSE-UP II Trial</brief_title>
	<detailed_description>Prospective , randomize ( 1:1 ) control , single blind , single center study 2000 percutaneous coronary intervention ( PCI ) patient compare ExoSeal VCD ( test device ) AngioSeal VCD ( standard comparator ) . In-hospital 30 day safety efficacy endpoints 6 month safety endpoint report .</detailed_description>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<criteria>Should able provide valid inform signed consent PCI procedure include treatment balloon and/or stent PCI indicate silent ischemia , stable angina pectoris , nonST elevation myocardial infarction ( NSTEMI ) ST elevation myocardial infarction ( STEMI ) Only coronary angiography Multiple puncture Active infection Groin haematoma closure procedure Sheath size &gt; 7 French Known pseudoaneurysm arteriovenous ( AV ) fistula ipsilateral groin Prior arterial surgery abdomen and/or low extremity Cardiogenic shock Life expectancy less one year The patient female childbearing potential possible pregnancy positive pregnancy test within 7 day index procedure lactate Simultaneous plan subsequent femoral vein access Allergy component closure material left groin Puncture site &lt; 30 day Peripheral artery disease patient include operator´s discretion except heavy calcification present access site operator 's discretion preclude insertion VCD</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>PCI</keyword>
</DOC>